989: Universal HbA1c screening versus conventional risk factor screening for the prediction of gestational diabetes - 01/01/20
Doi : 10.1016/j.ajog.2019.11.1000
Whitney Bender 1, Clare McCarthy 2, Jesse Chittams 3, Michal A. Elovitz 4, Samuel Parry 5, Celeste Durnwald 6
1 Hospital of the University of Pennsylvania, Philadelphia, PA
2 University of Pennsylvania, Philadelphia, PA
3 University of Pennsylvania Biostatistics Analysis Core, Philadelphia, PA
4 Maternal and Child Health Research Center, Department of Obstetrics & Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5 Maternal and Child Health Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
6 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Le texte complet de cet article est disponible en PDF.
Plan
© 2019
Publié par Elsevier Masson SAS.
Vol 222 - N° 1S
P. S614-S615 - janvier 2020 Retour au numéro
Article précédent
- 988: Category II patterns in the second stage preceding abnormal fetal pH: Prolonged decelerations matter
- Nandini Raghuraman, Julia D. Lopez, Methodius G. Tuuli, George A. Macones, Alison G. Cahill
- 990: In the absence of diabetes, an early elevated HbA1c is associated with adverse pregnancy outcomes
- Whitney Bender, Clare McCarthy, Jesse Chittams, Michal A. Elovitz, Samuel Parry, Celeste Durnwald
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?